DUBLIN, July 9, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) today announced that Samantha Pearce, Senior Vice President (SVP), Europe and International, has been promoted to Chief Commercial ...

Jazz Pharmaceuticals delivered a first quarter that was met with a positive response from the market, driven largely by strong commercial execution across its sleep, epilepsy, and oncology franchises.

(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) announced the commercial availability in Canada of Zepzelca (lurbinectedin), the first new treatment in Canada for adult patients with stage III or ...

Jazz Pharmaceuticals JAZZ reported second-quarter results highlighted by total revenue of $957 million, representing a 3% increase from the prior-year period. The strong patient uptake of Xywav (the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Jazz Pharmaceuticals JAZZ reported healthy first-quarter results highlighted by total revenue of $893 million, representing a 10% increase from the prior-year period thanks to the company’s ...